One of the major areas of research in the PCOS-prone JCR:LA-cp rodent model is understanding the distinct mechanisms of androgens and insulin in the cardiometabolic manifestations, particularly dyslipidemia and CVD risk (102, 107, 108). The gene discussed is INS; the disease is metabolic syndrome.